Can-Fite BioPharma Statistics Share Statistics Can-Fite BioPharma has 8.76M
shares outstanding. The number of shares has increased by 4.46%
in one year.
Shares Outstanding 8.76M Shares Change (YoY) 4.46% Shares Change (QoQ) 2.33% Owned by Institutions (%) 1.81% Shares Floating 4.88M Failed to Deliver (FTD) Shares 3 FTD / Avg. Volume n/a
Short Selling Information The latest short interest is 358.51K, so 2.7% of the outstanding
shares have been sold short.
Short Interest 358.51K Short % of Shares Out 2.7% Short % of Float 2.7% Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -1.5 and the forward
PE ratio is -21.15.
Can-Fite BioPharma's PEG ratio is
0.04.
PE Ratio -1.5 Forward PE -21.15 PS Ratio 17.54 Forward PS 0.1 PB Ratio 2.18 P/FCF Ratio -1.55 PEG Ratio 0.04
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Can-Fite BioPharma.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 4.38,
with a Debt / Equity ratio of 0.02.
Current Ratio 4.38 Quick Ratio 4.38 Debt / Equity 0.02 Debt / EBITDA -0.01 Debt / FCF -0.01 Interest Coverage -580.71
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $134.8K Profits Per Employee $-1.58M Employee Count 5 Asset Turnover 0.07 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -71% in the
last 52 weeks. The beta is 0.08, so Can-Fite BioPharma's
price volatility has been higher than the market average.
Beta 0.08 52-Week Price Change -71% 50-Day Moving Average 0.91 200-Day Moving Average 1.37 Relative Strength Index (RSI) 29.29 Average Volume (20 Days) 179,725
Income Statement In the last 12 months, Can-Fite BioPharma had revenue of 674K
and earned -7.88M
in profits. Earnings per share was -1.08.
Revenue 674K Gross Profit 674K Operating Income -8.13M Net Income -7.88M EBITDA -8.12M EBIT -8.13M Earnings Per Share (EPS) -1.08
Full Income Statement Balance Sheet The company has 4.83M in cash and 104K in
debt, giving a net cash position of 4.72M.
Cash & Cash Equivalents 4.83M Total Debt 104K Net Cash 4.72M Retained Earnings -166.36M Total Assets 9.12M Working Capital 6.93M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -7.64M
and capital expenditures -5K, giving a free cash flow of -7.64M.
Operating Cash Flow -7.64M Capital Expenditures -5K Free Cash Flow -7.64M FCF Per Share -1.05
Full Cash Flow Statement Margins Gross margin is 100%, with operating and profit margins of -1206.23% and -1169.14%.
Gross Margin 100% Operating Margin -1206.23% Pretax Margin -1169.14% Profit Margin -1169.14% EBITDA Margin -1205.19% EBIT Margin -1206.23% FCF Margin -1133.83%
Dividends & Yields CANF does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for CANF is $10,
which is 1392.5% higher than the current price. The consensus rating is "Buy".
Price Target $10 Price Target Difference 1392.5% Analyst Consensus Buy Analyst Count 2
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Jan 9, 2023. It was a
backward
split with a ratio of 1:10.
Last Split Date Jan 9, 2023 Split Type backward Split Ratio 1:10
Scores Altman Z-Score -26.54 Piotroski F-Score 2
